跳至主要内容
临床试验/NCT03310047
NCT03310047已完成1 期

Intra-individual Reproducibility in Nerve Block Duration

Nordsjaellands Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2017年10月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Duration of insensitivity towards cold

研究概览

简要总结

An interventional randomized controlled crossover trial, to illuminate if durations in nerve block durations are predictable within the same subject.

详细描述

An interventional randomized controlled crossover trial, with the purpose to elucidate the reproducibility in nerve block duration on 20 healthy volunteers in Denmark.

There will be two trial arms:

1: Day one; Right side low dose nerve block and left side high dose nerve block. Repeated after 24 hours. Day three; Left side low dose nerve block and right side high dose nerve block. Repeated after 24 hours

2: Day one; Left side low dose nerve block and right side high dose nerve block Repeated after 24 hours Day three; Right side low dose nerve block and left side high dose nerve block Repeated after 24 hours

All volunteers will receive two peripheral nerve blocking catheters adjacent to the common peroneal nerve and will be treated two times on each side with Lidocaine 0.5% 5 mL and 10 mL.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

The process of intervention-implementation and intervention will not be in the participant's line of sight.

Investigators will not be in the room during the intervention. Outcome assessors will not be in the room during the intervention.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age 18 years
  • •ASA classification ≤ II

排除标准

  • •Allergy to local anaesthetics
  • •Body weight 40 kg
  • •Possible peripheral nerve injury or disease, including polyneuropathy and diabetes
  • •Enrolment or recent participation in studies that may interfere with this study
  • •Habitual use of any kind of analgesic medications
  • •Anatomic abnormalities preventing successful US-guided Certa Catheter™ insertion.
  • •Pregnancy or breastfeeding

研究组 & 干预措施

Right-low, left-high

Experimental

The right-side perineural catheter will be subject to intervention drug Infusion, Lidocaine, 0.5%, 5 mL Lidocaine and the left side perineural catheter will be subject to intervention Infusion, Lidocaine, 0.5%, 10 mL.

This will be repeated after 24 hours.

干预措施: Infusion, Lidocaine, 0.5%, 10 mL (Drug)

Right-low, left-high

Experimental

The right-side perineural catheter will be subject to intervention drug Infusion, Lidocaine, 0.5%, 5 mL Lidocaine and the left side perineural catheter will be subject to intervention Infusion, Lidocaine, 0.5%, 10 mL.

This will be repeated after 24 hours.

干预措施: Infusion, Lidocaine, 0.5%, 5 mL (Drug)

Right-high, left-low

Experimental

The right-side perineural catheter will be subject to intervention drug Infusion, Lidocaine, 0.5%, 10 mL Lidocaine and the left side perineural catheter will be subject to intervention Infusion, Lidocaine, 0.5%, 5 mL.

This will be repeated after 24 hours.

干预措施: Infusion, Lidocaine, 0.5%, 10 mL (Drug)

Right-high, left-low

Experimental

The right-side perineural catheter will be subject to intervention drug Infusion, Lidocaine, 0.5%, 10 mL Lidocaine and the left side perineural catheter will be subject to intervention Infusion, Lidocaine, 0.5%, 5 mL.

This will be repeated after 24 hours.

干预措施: Infusion, Lidocaine, 0.5%, 5 mL (Drug)

结局指标

主要结局

Duration of insensitivity towards cold

时间窗: Up to 10 hours

Time from nerve block onset time (T1) to nerve block remission (T2)

次要结局

  • Onset time(Up to 30 minutes)
  • Degree of sensory nerve block(Up to 10 hours)
  • Degree of motor nerve block(Up to 10 hours)

研究者

发起方
Nordsjaellands Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mikkel Herold Madsen

Principal investigator

Nordsjaellands Hospital

研究点 (1)

Loading locations...

相似试验